EichorEICHOR
Condition: Acute Migraine Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Acute Migraine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Nerve Blocks for Episodic Migraine
Phase 2 · 1 location(s) · Mayo Clinic · NCT05734625A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Phase 1 · 13 location(s) · Pfizer · NCT06995729Gepant treAtments: EffectIveNess and tolERability (GAINER)
Phase N/A · 2 location(s) · University of Florence · NCT05903027Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Phase N/A · 1 location(s) · Brown University · NCT05754190Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Phase 4 · 11 location(s) · Pfizer · NCT07609914Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · 129 location(s) · AbbVie · NCT05125302Carotid Sinus Massage in Trendelenburg Position for Headache Relief
NA · 1 location(s) · Hospital Municipal Pedro T. Orellana · NCT06745648i-NEED: NEw migrainE Drugs Database
Phase N/A · 2 location(s) · IRCCS San Raffaele Roma · NCT07103694Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 124 location(s) · Pfizer · NCT04743141A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · 114 location(s) · Kallyope Inc. · NCT07674654Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Me
Phase 4 · 1 location(s) · Mayo Clinic · NCT06401642Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
Phase 2 · 1 location(s) · Sichuan Purity Pharmaceutical Technology Co., Ltd. · NCT07304518Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase
Phase N/A · 3 location(s) · AbbVie · NCT07310290A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · 114 location(s) · Kallyope Inc. · NCT07645924Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Atte
Phase 4 · 1 location(s) · Ain Shams University · NCT07022496Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder De
Phase 2 · 6 location(s) · Aspeya, Inc. · NCT07646613
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.